Trial
NCT02815293
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Allergan
Collaborators
—
Condition
Dry Eye Syndromes
Intervention
AGN-195263
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-19